Posted On: 10/09/2014 9:52:43 AM
Post# of 30015
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: Daveludlow #7955
I agree Dave. ICON has labs all over the world. AMBS does not have the capability to reach ex-US, but ICON does. ICON just might pay AMBS for rights to ex-US markets for Lympro in clinical trials. Just a guess. That makes the most sense to me at this point but could be a myriad of things.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)